Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...
“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...
DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...
Fit&Well on MSN
Forget abs—these are the core muscles we should all be training to reduce back pain and improve posture
The four main muscles of the deep core—transverse abdominis, multifidus, pelvic floor and the diaphragm—work together to keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback